-
Recent Posts
Recent Comments
- MichaelOrdman on Fighting over Israeli engineers
- Elaine Morales on Fighting over Israeli engineers
- MichaelOrdman on Enriched seaweed can feed the world
- Professor Rajan Rajan on Enriched seaweed can feed the world
- MichaelOrdman on Fast glaucoma treatment in trials
Archives
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- July 2010
Categories
Meta
Search Results for: dreamed diabetes
AI management approved for type 2 diabetes
Israel’s DreaMed (see here previously) has now received US FDA approval for use with Type 2 diabetes sufferers as well as Type 1. It will relieve the strain on endocrinologist who each have on average some 46,000 patients. https://www.timesofisrael.com/spotlight/israeli-startup-offers-hope-in-global-diabetes-crisis/
Posted in Israel's Medical Achievements
Leave a comment
Diabetes treatment in US
Israel’s DreaMed Diabetes (see here) has partnered a number of US health clinics. Lucile Packard Children’s Hospital Stanford; Billings Clinic Montana; Hassenfeld Children’s Hospital, NYU Langone and UF Health will provide diabetes patients with DreaMed’s personalized solutions. https://www.businesswire.com/news/home/20200930005419/en/DreaMed-Expands-Its-Remote-Diabetes-Solution-to-Four-Clinics-Across-The-U.S.
Posted in Israel's Medical Achievements
Leave a comment
FDA approves diabetes management system
I’ve reported previously (see here) on the diabetes monitors from Israel’s DreaMed. The US FDA has just given approval to DreaMed’s Advisor Pro, to add to its EU approval. The software tells Type 1 diabetics how much insulin to use, … Continue reading
Posted in Israel's Medical Achievements
Leave a comment
AI system for diabetes treatment
I reported previously (see here) on Israel’s DreaMed Diabetes monitors. DreaMed has just partnered with French company BioCorp to create an Artificially Intelligent system that integrates BioCorp’s Mallya smart cap for pen injectors with DreaMed’s Advisor Pro insulin analysis system. … Continue reading
Posted in Israel's Medical Achievements
Leave a comment
US approval for diabetes monitor
I reported previously (10th Mar) that Israel’s DreaMed received European approval for its Advisor Pro diabetes monitor. Now the US FDA has given its approval. Advisor Pro provides insulin delivery recommendations by analyzing information from diabetes pumps and glucose monitoring. … Continue reading
Posted in Israel's Medical Achievements
Leave a comment
Startup investment – to 25/8/24
Kubiya raised another $6 million; DreaMed Diabetes raised $3 million;
Posted in Economy & Business
Leave a comment
Treating diabetic children in Texas
Israel’s DreaMed Diabetes (reported here previously) is integrating its Advisor Pro software at Texas Children’s Hospital. It allows diabetic children to be monitored remotely and avoids the risk of them (and their parents / guardians) being infected in hospital with … Continue reading
Posted in Israel's Medical Achievements
Leave a comment
Glucose analyzer gets Europe approval
I reported previously (twice) about Israel’s DreaMed Diabetes monitors for analyzing the data from Continuous Glucose Monitors (CGMs). DreaMed has just received the CE mark from the European Union for its Advisor Pro product. https://www.timesofisrael.com/israeli-smart-software-harnesses-flood-of-data-to-manage-diabetes-care/ https://www.youtube.com/embed/_eMkeq0lrFc?rel=0
Posted in Israel's Medical Achievements
Leave a comment
Monitoring insulin levels
Israel’s DreaMed Diabetes is developing a decision support technology platform called the Advisor to determine optimal patient-specific insulin treatment plans leading to balanced glucose levels in people with diabetes. DreaMed has just raised $3.3 million for development. http://www.prnewswire.com/news-releases/dreamed-diabetes-raises-33-million-from-norma-investments-and-a-strategic-investor-300303138.html
Posted in Israel's Medical Achievements
Leave a comment
Diabetic technology goes global
Israeli medical tech firm DreaMed Diabetes has struck a deal with Medtronic, the world’s biggest medical device company, to use its MD-Logic Artificial Pancreas algorithm in Medtronic’s insulin pumps. The algorithm regulates the insulin released to the diabetic individual. http://www.timesofisrael.com/diabetics-worldwide-to-benefit-from-artificial-pancreas/
Posted in Israel's Medical Achievements
Leave a comment